Your browser is no longer supported. Please, upgrade your browser.
TEVA Teva Pharmaceutical Industries Limited daily Stock Chart
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-11.14 Insider Own2.70% Shs Outstand1.02B Perf Week7.74%
Market Cap24.66B Forward P/E8.56 EPS next Y2.83 Insider Trans2.72% Shs Float977.48M Perf Month5.03%
Income-11317.00M PEG- EPS next Q0.55 Inst Own66.80% Short Float3.81% Perf Quarter14.08%
Sales20.84B P/S1.18 EPS this Y-30.70% Inst Trans-0.53% Short Ratio3.55 Perf Half Y15.89%
Book/sh13.93 P/B1.74 EPS next Y1.80% ROA-14.00% Target Price21.09 Perf Year41.64%
Cash/sh1.83 P/C13.25 EPS next 5Y-9.77% ROE-60.40% 52W Range10.85 - 25.14 Perf YTD27.81%
Dividend0.85 P/FCF8.35 EPS past 5Y-57.50% ROI-36.00% 52W High1.41% Beta0.72
Dividend %3.51% Quick Ratio0.70 Sales past 5Y2.00% Gross Margin46.00% 52W Low134.96% ATR0.84
Employees51800 Current Ratio1.00 Sales Q/Q-17.30% Oper. Margin-53.90% RSI (14)65.87 Volatility4.26% 3.63%
OptionableYes Debt/Eq2.13 EPS Q/Q96.00% Profit Margin-49.20% Rel Volume1.80 Prev Close24.22
ShortableYes LT Debt/Eq2.04 EarningsAug 02 BMO Payout- Avg Volume10.48M Price25.49
Recom3.10 SMA2010.88% SMA508.50% SMA20030.65% Volume13,089,408 Change5.26%
Jun-27-18Reiterated Citigroup Buy $25 → $27
Mar-20-18Resumed Jefferies Hold $19
Feb-12-18Upgrade Credit Suisse Neutral → Outperform
Feb-09-18Upgrade RBC Capital Mkts Underperform → Sector Perform
Feb-09-18Downgrade Piper Jaffray Neutral → Underweight
Feb-09-18Downgrade Gabelli & Co Buy → Hold
Feb-02-18Downgrade BTIG Research Neutral → Sell $17
Jan-26-18Reiterated Leerink Partners Underperform $15 → $17
Jan-25-18Reiterated Susquehanna Positive $22 → $24
Jan-18-18Downgrade BTIG Research Buy → Neutral
Jan-09-18Upgrade Mizuho Neutral → Buy $23
Jan-05-18Downgrade Wells Fargo Market Perform → Underperform
Jan-04-18Upgrade Citigroup Neutral → Buy
Jan-03-18Initiated Leerink Partners Underperform $15
Dec-15-17Upgrade Morgan Stanley Underweight → Equal-Weight
Dec-15-17Upgrade Goldman Neutral → Buy
Dec-15-17Upgrade Credit Suisse Underperform → Neutral
Dec-12-17Initiated Guggenheim Neutral $16
Nov-29-17Reiterated Mizuho Neutral $12 → $16
Nov-17-17Reiterated Mizuho Neutral $15 → $12
Aug-19-18 11:21AM  Tevas generic EpiPen approved in the U.S., with perfect timing MarketWatch
Aug-17-18 04:17PM  Business + Coffee: Google employee protest, Teva generic EpiPen, Trump NFL sentiment Yahoo Finance Video
12:45PM  EpiPen Shortage 2018: 13 Things for Parents to Know InvestorPlace
12:31PM  Why the FDA's generic EpiPen approval is a big win for a N.J. company American City Business Journals
10:36AM  The FDA Finally Approves Generic EpiPen That May Be Cheaper Meredith Videos
10:29AM  Lifesaving EpiPen Device Still Out of Stock at Many Pharmacies Bloomberg
10:27AM  Mylan Suffers a Blow as Teva Gets FDA Nod for EpiPen Generic Zacks
09:25AM  Teva Gets FDA Nod for First Generic Version of Mylan's EpiPen Zacks
09:01AM  Regeneron, Teva Announce Positive Data on Osteoarthritis Drug Zacks
08:15AM  The Daily Biotech Pulse: Aveo Slips On Stock Offering, FDA Greenlights Generic EpiPen, Pfenex Exec Resigns Benzinga
08:00AM  Todays Research Reports on Stocks to Watch: Teva Pharmaceutical and Mylan ACCESSWIRE
07:31AM  If I Had to Buy 1 Stock in August, It Would Be This One Motley Fool
01:32AM  [$$] FirstFT: Todays top stories Financial Times
Aug-16-18 07:40PM  FDA Approves Tevas Generic Version of EpiPen Injector The Wall Street Journal +7.30%
04:31PM  Why Symantec, Teva Pharmaceutical Industries, and Century Aluminum Jumped Today Motley Fool
04:28PM  Teva Notches Win With FDA Approval of Generic EpiPen
04:22PM  Warren Buffetts warning on Walmart: There are better stocks than retailers CNBC
04:00PM  Teva Wins FDA Approval For Generic Epinephrine Benzinga
03:54PM  5 Top Stock Trades for Friday Morning Trading Nvidia Earnings InvestorPlace
01:45PM  U.S. FDA approves first generic of Mylan's EpiPen Reuters
01:36PM  FDA approves Teva's generic EpiPen CNBC Videos
01:25PM  FDA approves first rival generic EpiPen, sending Teva shares up 6% MarketWatch
01:10PM  U.S. FDA approves first generic version of Mylan's EpiPen Reuters
12:57PM  EpiPen Gets First Generic Rival After Furor Over High Price Bloomberg
12:55PM  FDA approves Tevas generic EpiPen after yearslong delay CNBC
07:00AM  Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip Business Wire
07:00AM  Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip PR Newswire
06:31AM  Why Warren Buffett's Still Gobbling Up Shares in This Generic Drugmaker Motley Fool
01:48AM  [$$] Teva shares climb after FDA approves its generic EpiPen Financial Times
Aug-15-18 04:21PM  Heat Biologics Stock Is a Worthwhile, Speculative Bet InvestorPlace
03:20PM  11 Stocks Warren Buffett Is Buying or Selling Kiplinger
11:53AM  Berkshire Hathaway adds to Apple, Teva stakes CNBC Videos
11:18AM  Buffett Ups Stake in Teva
10:36AM  3 Stocks for Warren Buffett Fans Motley Fool
08:00AM  Today's Research Reports on Trending Tickers: Teva Pharmaceutical and Canopy Growth ACCESSWIRE
Aug-14-18 07:06PM  Warren Buffett's firm adds to Apple, Teva investments Associated Press
05:42PM  Berkshire boosts Goldman, Teva stakes; buys more Apple Reuters
05:39PM  Warren Buffett's firm adds to Apple, Teva investments Associated Press
05:01PM  Stocks making the biggest moves after hours: EGN, TEVA & more CNBC
04:40PM  Berkshire Hathaway increases stakes in Apple, Goldman and... CNBC Videos
Aug-13-18 12:01AM  The Unlikely Source of a Healthtech Revolution Bloomberg
Aug-08-18 05:41PM  Bausch Health Companies (BHC) Q2 2018 Earnings Conference Call Transcript Motley Fool
04:23PM  Mylan Exploring Options As 'Unsustainable' Trends Hound Sales, Profit Investor's Business Daily
Aug-07-18 09:30AM  TEVA vs. TLGT: Which Stock Is the Better Value Option? Zacks +5.25%
Aug-06-18 04:08PM  Does Bausch Face A Reckoning? 5 Key Issues To Look For In Its Earnings Investor's Business Daily
08:00AM  Teva Announces Updated Indication and Vial Presentation for GRANIX® (tbo-filgrastim) Injection in United States Business Wire
Aug-03-18 04:00PM  Teva Chief Says Generic Prices Are Improving Will Its Stock Also Do So? Investor's Business Daily
12:14PM  [$$] Israel's Fledgling Hedge Funds Post Strong Gains
11:22AM  Teva (TEVA) Q2 Earnings Beat, Revenues Miss, Stock Down Zacks
09:33AM  Company News For Aug 3, 2018 Zacks
08:20AM  Teva stock drops 10% as generics turnaround looks uncertain MarketWatch
Aug-02-18 07:42PM  [$$] Teva Pharmaceuticals Sales Slump 18% The Wall Street Journal -9.47%
04:36PM  Why Wynn Resorts, Red Robin Gourmet Burgers, and Teva Pharmaceutical Industries Slumped Today Motley Fool
03:00PM  Teva Earnings: Is It Time to Worry?
02:01PM  Why Teva Pharmaceutical Stock Is Sinking Today InvestorPlace
12:48PM  [$$] Teva's Sales Slump 18% The Wall Street Journal
12:26PM  Teva Pharma Dives As Another Drugmaker Breaks Out On Earnings Investor's Business Daily
11:19AM  Teva Pharma shares sink as sales forecast disappoints market Reuters
10:45AM  Teva Pharm shares sink as sales forecast disappoints market Reuters
09:19AM  Teva (TEVA) Beats on Q2 Earnings, Misses Sales, Shares Dip Zacks
08:54AM  [$$] Teva Shares Drop After Fall in Sales The Wall Street Journal
08:05AM  Stocks making the biggest moves premarket: DWDP, TSLA, NKE, SBUX, YUM & more CNBC
07:22AM  Teva stock drops 4.5% in spite of Q2 profit beat, revenue match MarketWatch
07:14AM  Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion Bloomberg
07:08AM  Teva Pharm Q2 profit beats estimates, raised full year outlook Reuters
07:00AM  Teva Reports Second Quarter 2018 Financial Results Business Wire
Aug-01-18 03:43PM  Teva Pharmaceutical's Earnings Preview Benzinga
Jul-30-18 10:49AM  Teva (TEVA) Q2 Earnings Coming Up: What's in the Cards? Zacks
Jul-27-18 09:34AM  Dr. Reddy's (RDY) Earnings and Revenues Improve Y/Y in Q1 Zacks
Jul-20-18 05:43PM  Pfizer gets FDA approval for drug similar to Amgen's Neupogen MarketWatch
Jul-18-18 09:12PM  New Drugs and Expected Growth Could Trigger a Recovery for Celgene Stock InvestorPlace
Jul-17-18 08:37AM  Benzinga's Daily Biotech Pulse: Bellicum CFO Resigns, Roche's Trial Meets Endpoints, Avid Bioservices Turns To Black In Q4 Benzinga
08:30AM  Teva Highlights Key Milestones Achieved in the 2017 Social Impact Report Business Wire
Jul-16-18 03:24PM  Blood Pressure Medication That May Contain Cancer-Causing Impurity Is Recalled Fortune
Jul-15-18 04:51PM  Here's How Teva Pharmaceuticals Pulled Off a 28.3% Gain in the First Half of 2018 Motley Fool
Jul-13-18 08:24PM  3 Warren Buffett Stocks Worth Buying Now Motley Fool
05:58PM  FDA recalls heart drugs made by Teva, others over carcinogen impurity MarketWatch
08:49AM  4 Warren Buffett Stocks to Buy in Q2 Earnings Zacks
Jul-11-18 09:30AM  Has Teva Pharmaceutical Industries (TEVA) Outpaced Other Medical Stocks This Year? Zacks
08:00AM  Teva to Report Second Quarter 2018 Financial Results on August 2, 2018 Business Wire
Jul-09-18 12:19PM  Correction: Teva-US-HQ Move story Associated Press
10:47AM  Teva Announces Launch of a Generic Version of Uceris® in the United States Business Wire
09:30AM  TEVA or AKRX: Which Is the Better Value Stock Right Now? Zacks
08:58AM  Up in the air: Teva's 1M square feet of space in the suburbs American City Business Journals
07:25AM  Complimentary Technical Snapshots on Teva Pharma Industries and Three More Drug Makers Stocks ACCESSWIRE
Jul-06-18 05:15PM  Pharma firm Teva moving HQ to New Jersey from Pennsylvania Associated Press
02:33PM  Teva's decision to move North American HQ leaves other sites in jeopardy American City Business Journals
10:56AM  5 Pharmaceutical and Biotech Stocks to Consider for July InvestorPlace
Jul-05-18 01:52PM  Teva moving North America headquarters from North Wales to North Jersey American City Business Journals
Jun-29-18 08:10AM  Todays Research Reports on Stocks to Watch: Teva Pharmaceuticals and Gemphire Therapeutics ACCESSWIRE
Jun-28-18 08:00AM  Teva to Present New Fremanezumab Data, Including Long-Term Data, at the American Headache Societys 60th Annual Scientific Meeting Business Wire
Jun-27-18 01:13PM  Medial Devices & Teva. Plus, the bullish bet on this food... CNBC Videos
11:25AM  Stocks - ConAgra, Pinnacle Foods Tumble in Pre-Market, WWE Surges
Jun-26-18 06:31AM  3 Best Big Pharma Stocks of 2018 So Far Motley Fool
Jun-21-18 12:12PM  Mylan Stock Looks Cheap, but Dont Overlook These Risks InvestorPlace
Jun-19-18 01:25PM  CVS will offer home delivery of prescriptions Yahoo Finance Video
Jun-18-18 10:08AM  Teva to Discontinue a Fremanezumab Study on Cluster Headache Zacks
Jun-15-18 05:01PM  Teva Scraps A Study In Cluster Headaches And This Rival Benefits Investor's Business Daily
04:45PM  Here's Why Alder Biopharmaceuticals Is Rising Today Motley Fool
09:32AM  Teva Pharmaceutical Industries Limited Stock Still Is a Deep Value Play InvestorPlace
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides specialty medicines for use in central nervous system and respiratory indications. Its products in the central nervous system area comprise Copaxone for the treatment of relapsing forms of MS; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. The company has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Codner Iris BeckEVP Global Brand&CommunicationAug 09Sale22.704,16594,5418,290Aug 13 08:34 AM
Dethlefs SvenEVP Global Marketing&PortfolioAug 03Buy21.922,00043,8406,445Aug 07 09:45 AM
MIGNONE ROBERTODirectorMay 10Buy19.32250,0004,829,7001,500,000May 11 04:15 PM
MIGNONE ROBERTODirectorMay 09Buy19.21500,0009,603,1501,250,000May 11 04:15 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 19Sale18.382,35843,3402,974Mar 20 04:16 PM
O'Grady Brendan P.EVP, North America CommercialMar 19Sale17.881,17921,0781,388Mar 20 04:13 PM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 19Sale17.894578,1775,746Mar 20 04:11 PM
McClellan Michael JamesEVP, Chief Financial OfficerMar 19Sale17.882875,13111,295Mar 20 04:10 PM
Griffin Deborah AChief Accounting OfficerMar 19Sale17.8894316,8590Mar 20 04:08 PM
Fridriksdottir HafrunExecutive VP, Global R&DMar 19Sale17.883486,2227,051Mar 20 04:07 PM
Dethlefs SvenEVP Global Marketing&PortfolioMar 19Sale17.8857110,2084,445Mar 20 04:06 PM
Daniell RichardExec. VP, European CommercialMar 19Sale17.891,29723,2060Mar 20 04:04 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 12Sale19.202,44146,8672,974Mar 14 04:35 PM
O'Grady Brendan P.EVP, North America CommercialMar 12Sale19.4973814,3831,388Mar 14 04:34 PM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 12Sale19.504618,9895,331Mar 14 04:31 PM
Griffin Deborah AChief Accounting OfficerMar 12Sale19.4995218,5540Mar 14 04:29 PM
Dethlefs SvenEVP Global Marketing&PortfolioMar 12Sale19.4957611,2263,837Mar 14 04:26 PM
Daniell RichardExec. VP, European CommercialMar 12Sale19.5071413,9220Mar 14 04:23 PM
O'Grady Brendan P.EVP, North America CommercialMar 05Sale19.3870513,6631,388Mar 06 04:20 PM
Griffin Deborah AChief Accounting OfficerMar 05Sale19.3877314,9810Mar 06 04:14 PM
Daniell RichardExec. VP, European CommercialMar 05Sale19.281,10821,3620Mar 06 04:08 PM
Sabag MarkEVP, Global Human ResourcesFeb 15Sale20.523,00061,56041,517Feb 20 08:31 AM
Sabag MarkEVP, Global Human ResourcesFeb 14Sale18.452,05037,82344,517Feb 20 08:31 AM